Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Events

Events

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Events
  • News

Rackspace Technology To Showcase Purpose-Built Generative Artificial Intelligence Applications From Foundry For AI By Rackspace At AWS re:Invent 2023

By Benzinga Newsdesk
November 21, 12:28 PM
Rackspace Technology® (NASDAQ:RXT), a leading end-to-end hybrid multicloud technology solutions, announced celebrating twelve years of attending AWS re:Invent with a futuristic booth activation, a breakout session

AMZN

Read More
1 minute read
  • Biotech
  • Events
  • General
  • News

Connect Biopharma To Announce Long-Term Data From The China Pivotal Trial Of Rademikibart In Patients With Moderate-To-Severe Atopic Dermatitis On November 21, 2023

By Benzinga Newsdesk
November 20, 5:42 PM
Connect Biopharma Holdings Limited (NASDAQ:CNTB) ("Connect Biopharma" or the "Company"), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases

CNTB

Read More
3 minute read
  • Bonds
  • Broad U.S. Equity ETFs
  • Commodities
  • Economics
  • ETFs
  • Events
  • Federal Reserve
  • Fintech
  • Macro Economic Events
  • Real Estate
  • Sector ETFs
  • Small Cap
  • Tech
  • Top Stories

US Stock Market Posts Another Week Of Gains As Inflation Softens: This Week In The Markets

By Piero Cingari
November 17, 5:36 PM
Stock markets have notched their third successive week of gains, buoyed by inflation data falling short of forecasts. The Fed futures market anticipates four rate cuts in 2024.

ADI

Read More
2 minute read
  • Cryptocurrency
  • Events
  • Fintech

Fortune 500 And Bitcoin: Top Public Companies Embrace Crypto

By Stjepan Kalinic
November 17, 4:28 PM
Coinbase reported 83% of the surveyed Fortune 500 executives either planned or had blockchain initiatives on the way.

AMZN

Read More
2 minute read
  • Events
  • News

Blink CEO, Brendan Jones, To Discuss Blink’s Continuous Record Growth And Path To Profitability At UBS Industrials Summit On November 29

By Benzinga Newsdesk
November 17, 2:20 PM
Blink Charging Co. (NASDAQ:BLNK) ("Blink" or the "Company"), a leading global manufacturer, owner, operator, and provider of electric vehicle (EV) charging equipment and services, today announced that Brendan Jones,

BLNK

Read More
3 minute read
  • Events
  • Global
  • News

Significant BlackBerry Cybersecurity Deal With The Government Of Malaysia At APEC Leaders’ Summit Welcomed By Canadian And Malaysian Prime Ministers

By Benzinga Newsdesk
November 17, 9:12 AM
BlackBerry to provide full suite of cybersecurity solutions to Government of Malaysia in milestone long-term dealSAN FRANCISCO, Nov. 17, 2023 /PRNewswire/ -- The Government of Malaysia and BlackBerry Limited (NYSE:BB,

BB

Read More
5 minute read
  • Biotech
  • Events
  • General
  • News

Humacyte Announces Two Presentations At The VEITHsymposium Of Clinical Results Of The Human Acellular Vessel In The Treatment Of Vascular Trauma

By Benzinga Newsdesk
November 17, 9:07 AM
– Presentations included results from Phase 2/3 clinical trial and outcomes of real-world use of the HAV under a humanitarian aid program to treat wartime injuries in Ukraine – – Results showed the HAV had higher

HUMA

Read More
3 minute read
  • Cryptocurrency
  • Events
  • Exclusives
  • Interview
  • Markets
  • News
  • Top Stories

EXCLUSIVE: Ripple’s Brendan Berry On 2024 Trends, Why Crypto’s ‘Second Wave’ Is All About Utility

By Anthony Noto
November 16, 4:06 PM
Earlier this year, Ripple expressed optimism that following a pivotal court decision not classifying XRP (CRYPTO: XRP) as a security, U.S.

$XRP

Read More
2 minute read
  • Bonds
  • ETFs
  • Events
  • Exclusives
  • Fintech
  • Markets
  • News

Shrek Royalties To T-Bills: Disruptive Diversification Of New Breed Of Retail Platforms

By Neil Dennis
November 15, 2:06 PM
"Our first asset was based on the score of the Shrek movies," Stephen Sikes, COO at Public.com, says at Benzinga's Fintech Deal Day event.

CMDY

Read More
2 minute read
  • Cryptocurrency
  • Events
  • Exclusives

EXCLUSIVE: As Major Brands Explore Web3, ‘Expect NFT Bull Run Peak In 2 Or 3 Years’

By Surbhi Jain
November 15, 11:43 AM
Alex Salnikov, co-founder of Rarible and Charlie O'Neill, senior manager, Emerging Partnerships at American Express share views on NFTs and Web3 adoption.

AXP

Posts pagination

Previous 1 … 20 21 22 … 128 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service